SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

Fei Han1, Wen-bin Liu1, Jian-jun Li2

  • 1Institute of Toxicology, College of Preventive Medicine

Endocrine-Related Cancer
|January 30, 2020
PubMed